---
$id: https://graph.org.ai/products/commodity/51392223
$type: Product
source: UNSPSC
code: "51392223"
title: "Indanazoline hydrochloride"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Indanazoline hydrochloride

**UNSPSC Code**: 51392223
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H15N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z364A90IV8, chemically known as 2-imidazoline, 2-(4-indanylamino)-, hydrochloride but more generally known as indanazoline hydrochloride, which bears US NIH Compound Identifier 162014. European Medicines Agency schedules Indanazoline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02661MIG. Most nations, for tariff and trade purposes, schedule indanazoline hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, INDANAZOLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Indanazoline hydrochloride bears US NLM identifiers UMLS ID C1609361 and NCI Concept Code C97700. SMILES: C1CC2C(C(C1)NC3=NCCN3)CCC2.CL.

